老葡京手机app

rnationalmarket'strustinChinese-developedCOVID-19vaccines. Thevaccine,arecombinantadenovirusvaccinenamedAd5-nCoV,isco-developedbyChinesebiopharmaceuticalfirmCanSinoBiologicsInc.,oneofthevaccinecandidate'sco-developers,andateamledbyChinesemilitaryinfectiousdiseaseexpertChenWei. AccordingtoadocumentpublishedonthewebsiteofChina'sNationalIntellectualPropertyAdministration,thevaccinecanstartmassproductioninashorttimeperiodincaseofanoutbreak. Thegrantofthepatentfurtherconfirmedthevaccine'sefficacyandsafety,andconvincinglydemonstratedtheownershipofitsintellectualpropertyrights(IPR),CanSm

老葡京手机app

inosaidinastatementonSunday. TaoLina,aShanghai-basedvaccineexpert,believedthaH

老葡京手机app

tthepatentgrantwouldprobablyfacilitatethemarketingprocess.AnofficiallygrantedpatentwouldalsoenhancetheconfidenceinChinese-developedCOVID-19vaccinesbyY

老葡京手机app

themarket,especiallytheinternationalmarket,addedTao.ofgeneral. TheceremonywasheldbytheCMCinBeijing.GeneralisthehigA